SHIM
DNA icon

Spruce House Investment Management’s Ginkgo Bioworks DNA Stock Holding History

Spruce House Investment Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-37,500
Closed -$12.5M – 11
2021
Q4 		$12.5M Hold
37,500
– – 0.39% 10
2021
Q3 		$17.4M Buy
+37,500
New +$18.3M 0.45% 11

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Spruce House Investment Management's DNA Position: Q1 2022 in Review

Spruce House Investment Management sold out of Ginkgo Bioworks (DNA) in Q1 2022, closing a stake of 37,500 shares — an estimated $12.5M sold.

Spruce House Investment Management first reported a position in DNA in Q3 2021 and held it in 2 quarters. The position peaked at $17.4M in Q3 2021. 190 funds tracked by Wall St. Rank hold DNA as of Q1 2022.

  • Spruce House Investment Management reported no remaining Ginkgo Bioworks position as of Q1 2022 after selling out during the quarter.
  • Spruce House Investment Management sold 37,500 Ginkgo Bioworks shares in Q1 2022, an estimated $12.5M.
  • Spruce House Investment Management first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 2 quarters.
  • Spruce House Investment Management's Ginkgo Bioworks position peaked at $17.4M in Q3 2021.
  • 190 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2022.

Based on Spruce House Investment Management's 13F filing for Q1 2022, filed 16 May 2022.